Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials.
about
Obesity and head and neck cancer risk and survival by human papillomavirus serology.Diet-induced unresolved ER stress hinders KRAS-driven lung tumorigenesis.Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone MetastasesPredictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.Overweight and obesity predict better overall survival rates in cancer patients with distant metastases.Prognostic factors for long term survival in patients with advanced non-small cell lung cancer.Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma.Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis.Progress in the application and mechanism of metformin in treating non-small cell lung cancer.Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients.Effect of metabolic syndrome and its components on recurrence and survival in early-stage non-small cell lung cancer.Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer.The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer.Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer.Impact of sarcopenic overweight on the outcomes after living donor liver transplantation.Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis.Impact of body mass index on surgical outcomes of gastric cancer.Influence of body mass index on the therapeutic efficacy of gemcitabine plus cisplatin and overall survival in lung squamous cell carcinoma.
P2860
Q34998853-3B8B409C-D8A5-4BD3-B18E-BE217AA5C392Q35008552-630BCC5F-80E6-4F23-BC2E-88D4D7E64C63Q35469145-A70ED821-67C9-4F6D-932B-F57ABACFDF9CQ35873227-0E6EBAC5-958D-42FE-B754-6889DE9404F7Q35874455-731FE8B0-EB43-4E0E-8717-6B470814605BQ36216134-2AE36364-AC70-4255-97C0-B0DBE1BD4606Q36524522-E91237E0-9C5A-43D2-9B70-067DFCE7D20DQ36797278-672ED353-7584-4184-8C7B-638D829490E2Q36924926-FA6B8F05-5BB7-41FC-868A-265F265AD0E6Q37643560-1A5352C5-6337-4958-BEAA-DB46882B174DQ37692130-E5B1F5B3-D257-4D42-A081-D8B721F04310Q38682839-1EF0C6BE-BF5C-47B7-AA27-90376B78F988Q39321321-BB72B339-CC37-45EC-9E0B-90AB1F2725D6Q39741230-9BDE59E3-CCBC-4081-8185-6880AFEC8F6CQ41725990-354B88E1-FF4B-4438-90C6-5E05C148C1D0Q46018831-19D2C540-8BEB-4D16-88AD-D99F7747C586Q46880522-C26F27E5-6B61-40B8-AAFE-4DEB5875E1B1Q47174806-71300C02-5B5E-441A-A276-9AB01F411CE0Q47290527-7BFBD87F-9E81-4696-821B-FD082644DCBCQ47356300-42416636-DA8A-407A-98B6-53C3FF1BE764Q48145666-09C7D972-D50F-4785-ACB2-57EAE1FF7D1BQ49375084-A56AACEB-BDC0-4F08-9CF9-08BF0E809857Q49418567-7579130F-25DB-411F-AA15-E968E8843809
P2860
Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Body mass index and its associ ...... ncology Group clinical trials.
@en
Body mass index and its associ ...... ncology Group clinical trials.
@nl
type
label
Body mass index and its associ ...... ncology Group clinical trials.
@en
Body mass index and its associ ...... ncology Group clinical trials.
@nl
prefLabel
Body mass index and its associ ...... ncology Group clinical trials.
@en
Body mass index and its associ ...... ncology Group clinical trials.
@nl
P2093
P2860
P1476
Body mass index and its associ ...... Oncology Group clinical trials
@en
P2093
Alan B Sandler
David H Johnson
Joan H Schiller
Julie R Brahmer
Philip B Bonomi
Suresh S Ramalingam
P2860
P304
P356
10.1097/JTO.0B013E31829CF942
P577
2013-09-01T00:00:00Z